( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
56670.4
56436.1
50961.6
55038.8
Total Expenditure
44932.2
44533.8
39959
41149.2
PBIDT (Excl OI)
11738.2
11902.3
11002.6
13889.6
Other Income
117.1
16.4
40.4
84.4
Operating Profit
11855.3
11918.7
11043
13974
Exceptional Items
1569.5
NA
NA
NA
PBDT
13424.8
11918.7
10574.1
13599
Depreciation
1744.1
1633.5
1569.4
1553.4
Profit Before Tax
11680.7
10285.2
9004.70
12045.6
Tax
1500.1
2753.2
2412.4
3186.8
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
10180.6
7532
6592.30
8858.79
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
10180.6
7532
6592.30
8858.79
Minority Interest
NA
NA
NA
NA
Shares of Associates
-196.4
-100.3
-126.4
-124.2
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
9984.2
7431.7
6465.9
8734.6
Equity Capital
1928.3
1928.3
964.2
964.2
Reserves
52171.3
42415.8
45594.3
39137.9
Calculated EPS
5.17
3.85
6.70
9.05
Calculated EPS (Annualised)
20.71
15.41
26.82
36.23
No of Public Share Holdings
718012740
718012740
718012740
359006370
% of Public Share Holdings
37.24
37.24
37.24
37.24
PBIDTM% (Excl OI)
20.71
21.08
21.58
25.23
PBIDTM%
20.91
21.11
21.66
25.38
PBDTM%
23.68
21.11
20.74
24.70
PBTM%
20.61
18.22
17.66
21.88
PATM%
17.96
13.34
12.93
16.09